{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:29:18Z","timestamp":1789871358683,"version":"4.0.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1007\/s11883-001-0022-y","type":"journal-article","created":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T18:52:59Z","timestamp":1179859979000},"page":"295-298","source":"Crossref","is-referenced-by-count":18,"title":["Botulinum toxin for the management of muscle overactivity and spasticity after stroke"],"prefix":"10.1007","volume":"3","author":[{"given":"A.","family":"Esquenazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0003-9993(94)90161-9","volume":"75","author":"H Nakayama","year":"1994","unstructured":"Nakayama H, Jorgensen HS, Raaschou HO, et al.: Recovery of upper extremity function in stroke patients: the Copenhagen stroke study. Arch Phys Med Rehab 1994, 75: 394\u2013398.","journal-title":"Arch Phys Med Rehab"},{"key":"22_CR2","doi-asserted-by":"crossref","unstructured":"Mayer NH, Esquenazi A, Childers MK: Common patterns of clinical motor dysfunction. Muscle Nerve 1997, (suppl 6):21\u201335.","DOI":"10.1002\/(SICI)1097-4598(1997)6+<21::AID-MUS4>3.0.CO;2-L"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/026921500666642221","volume":"14","author":"SJ Smith","year":"2000","unstructured":"Smith SJ, Ellis F, White S, Moore AP: A double-blind placebo controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000, 14: 5\u201313.","journal-title":"Clin Rehabil"},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","volume":"21","author":"AM Bakheit","year":"2000","unstructured":"Bakheit AM, Thilmann AF, Ward AB, et al.: A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000, 21: 2402\u20132406.","journal-title":"Stroke"},{"key":"22_CR5","first-page":"147","volume":"15","author":"M Panizza","year":"2000","unstructured":"Panizza M, Castagna M, di Summa A, et al.: Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX). Funct Neurol 2000, 15: 147\u2013155.","journal-title":"Funct Neurol"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jnnp.69.2.217","volume":"69","author":"BB Bhakta","year":"2000","unstructured":"Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM: Impact of botulinum toxin type A on disability and career burden due to arm spasticity after stroke: a randomized double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 2000, 69: 217\u2013221.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp.69.4.499","volume":"69","author":"D Richardson","year":"2000","unstructured":"Richardson D, Sheean G, Werring D, et al.: Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neuroserg Psychiatry 2000, 69: 499\u2013506.","journal-title":"J Neurol Neuroserg Psychiatry"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0885-3924(00)00146-9","volume":"20","author":"J Wissel","year":"2000","unstructured":"Wissel J, Muller J, Dressnandt J, et al.: Management of spasticity associated pain with botulinum toxin A. J Pain Sympt Manag 2000, 20: 44\u201349.","journal-title":"J Pain Sympt Manag"},{"key":"22_CR9","first-page":"183","volume-title":"Treatment of Movement Disorders","author":"MF Brin","year":"1995","unstructured":"Brin MF, Jankovic J, Comella C, et al.: Treatment of dystonia using Botulinum Toxin. In Treatment of Movement Disorders. Edited by Kurlan R. New York: Lippincott; 1995:183\u2013246."},{"key":"22_CR10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00002060-200007000-00010","volume":"79","author":"G Lagalla","year":"2000","unstructured":"Lagalla G, Danni M, Reiter F, et al.: Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil 2000, 79: 377\u2013384.","journal-title":"Am J Phys Med Rehabil"},{"key":"22_CR11","unstructured":"Cionni M, Hirai B, Esquenazi A: Differential gait strategies of individuals with spasticity, induced by the temporary diagnostic block and by the block of calf muscles with botulinum toxin type A. Presented at the Gait and Clinical Movement Analysis Society meeting. Sacramento, CA, April 2001."},{"key":"22_CR12","unstructured":"Brashear A, Gordon MF, Elovic E, et al. for the BOTOX Post-Stroke Study Group: A multicenter, double-blind, randomized, placebo-controlled, parallel study of the safety and efficacy of BOTOX (botulinum toxin A) purified neurotoxin in the treatment of focal upper limb spasticity post-stroke. Neurology 2001, in press."},{"key":"22_CR13","unstructured":"Mayer NH, Esquenazi A: Effect of botulinum toxin A on quantitative dynamic electromyographic parameters. Submitted for publication."}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-001-0022-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-001-0022-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-001-0022-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:35:20Z","timestamp":1559432120000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-001-0022-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11883-001-0022-y","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}